Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

The 2012 criteria are better for diagnosing atypical lupus cases.

Induced pluripotent stem cells are a major breakthrough in regenerative medicine.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.

Celiac disease requires more than just a gluten-free diet for effective management.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

New cancer treatments aim to reduce side effects and improve effectiveness.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

PCOS is linked to inflammation, and certain markers could help in its treatment.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

MicroRNAs could help assess and manage multiple chronic diseases.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.